Медицинский совет (Dec 2015)

Citicoline for ischemic stroke: from acute phase to rehabilitation

  • D. V. Sergeev,
  • M. A. Domashenko,
  • M. A. Piradov

DOI
https://doi.org/10.21518/2079-701X-2015-18-6-10
Journal volume & issue
Vol. 0, no. 18
pp. 6 – 10

Abstract

Read online

Effective pathogenetic therapy of ischemic stroke - reperfusion intervention - is largely restricted by mandatory careful selection of patients and availability of specialized care. Pharmacological treatments are therefore becoming especially relevant as they are aimed at maintaining viability of neurons in the ischemic area. The most studied and promising neuroprotectives are citicolines. They improve outcomes in individual groups of patients with acute ischemic stroke, and have beneficial effects on cognitive function in the recovery period. The drug also proved to be effective in the recovery of upper limb function in patients with hemiplegia. Citicoline can be recommended both for acute ischemic stroke and at the rehabilitation stage.

Keywords